Engineers Gate Manager’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History

Engineers Gate Manager’s Portfolio ODT Stock Details ODT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-18,822	Closed	-$25K	–	2518
2021 Q4	$25K	Buy	18,822 +6,949	+59%	+$16.4K	﹤0.01%	1929
2021 Q3	$35K	Sell	11,873 -12,786	-52%	-$42.5K	﹤0.01%	1580
2021 Q2	$86K	Sell	24,659 -10,185	-29%	-$35K	0.01%	1519
2021 Q1	$119K	Sell	34,844 -2,341	-6%	-$44.2K	0.01%	1691
2020 Q4	$714K	Sell	37,185 -49,786	-57%	-$768K	0.03%	757
2020 Q3	$1.17M	Buy	+86,971	New	+$2.46M	0.05%	533
2020 Q1	–	Sell	-11,560	Closed	-$375K	–	2060
2019 Q4	$375K	Sell	11,560 -3,749	-24%	-$116K	0.02%	1138
2019 Q3	$398K	Buy	15,309 +1,325	+9%	+$44.3K	0.02%	886
2019 Q2	$513K	Buy	+13,984	New	+$335K	0.03%	713

Other funds holding ODT

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Engineers Gate Manager's ODT Position: Q1 2022 in Review

Engineers Gate Manager sold out of Odonate Therapeutics, Inc. Common Stock (ODT) in Q1 2022, closing a stake of 18,822 shares — an estimated $25K sold.

Engineers Gate Manager first reported a position in ODT in Q2 2019 and held it in 9 quarters. The position peaked at $1.17M in Q3 2020. 8 funds tracked by Wall St. Rank hold ODT as of Q1 2022.

Engineers Gate Manager reported no remaining Odonate Therapeutics, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
Engineers Gate Manager sold 18,822 Odonate Therapeutics, Inc. Common Stock shares in Q1 2022, an estimated $25K.
Engineers Gate Manager first reported a position in Odonate Therapeutics, Inc. Common Stock in Q2 2019 and held it in 9 quarters.
Engineers Gate Manager's Odonate Therapeutics, Inc. Common Stock position peaked at $1.17M in Q3 2020.
8 funds tracked by Wall St. Rank held Odonate Therapeutics, Inc. Common Stock as of Q1 2022.

Based on Engineers Gate Manager's 13F filing for Q1 2022, filed 16 May 2022.